Back to results
US 7,745,408 B2Granted
Method of inducing melanogenesis in humans with MC1R variant alleles
AssigneeClinuvel Pharmaceuticals Limited
InventorStuart Michael Humphrey
Life of this patent
Estimating the term…
Abstract
A method for inducing melanogenesis in a human subject having a melanocortin 1 receptor (MC1R) variant allele associated with loss of or diminished receptor function comprises administering to said subject an amount of an α-melanocyte stimulating hormone (α-MSH) analogue effective to induce melanogenesis by the melanocytes in the skin or other epidermal tissue of the subject.
Claims9
A method for inducing melanogenesis in a human subject having a melanocortin 1 receptor (MC1R) variant allele associated with loss of or diminished receptor function, which comprises the steps of:
- i) identifying the MC1R variant using primer sequences selected from 5′-tggacaggactatggctgtg-3′ (MC1R-1F—SEQ ID NO:1), 5′-tcttcagcacgctcttcat-3′ (MC1R-1R—SEQ ID NO:2), 5′cttctacgcactgcgctacc-3′ (MC1R-2F—SEQ ID NO:
- 3) and 5′-gctttaagtgtgctgggcag-3′ (MC1R-2R—SEQ ID NO:
- 4), and
- ii) administering to said subject an amount of [Nle4, DPhe7]-α-melanocyte stimulating hormone ([Nle4, DPhe7]-α-MSH) effective to induce melanogenesis by the melanocytes in the skin or other epidermal tissue of the subject.
1 more element
Dependencies are inferred from the claim text.